Padmanabh Inds.

Why is Padmanabh Industries Ltd falling/rising?

As of 31-Aug, Padmanabh Industries Ltd's stock price is at 8.31, down 2.12%, and has underperformed against the Sensex. The stock shows a bearish trend, trading below multiple moving averages, with a significant drop in investor participation indicating a lack of confidence.

As of 31-Aug, Padmanabh Industries Ltd's stock price is falling, currently at 8.31, which reflects a decrease of 0.18 or 2.12%. The stock has underperformed compared to the benchmark Sensex, which has only declined by 0.53% over the past week. Additionally, the stock has shown a negative performance over various periods, with a 1-week decline of 5.14% and a year-to-date decrease of 8.08%. <BR><BR>The stock is trading below its moving averages across multiple time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. Furthermore, there has been a significant drop in investor participation, with delivery volume on August 28 falling by 69.53% compared to the 5-day average. This decline in trading activity suggests a lack of confidence among investors, contributing to the stock's downward movement. Overall, these factors collectively explain the current decline in Padmanabh Industries Ltd's stock price.

Who are in the management team of Padmanabh Inds.?

The management team of Padmanabh Industries includes Pranav Manoj Vajani (Independent Director), Chiragkumar Rameshbhai Parmar (Managing Director & CFO), Shvetalben S. Dataniya (Chairman & Independent Director), Viren Rajeshkumar Makwana (Additional Director), and Jayesh L Bhavsar (Company Secretary & Compliance Officer).

The management team of Padmanabh Industries includes the following individuals:<BR><BR>1. **Pranav Manoj Vajani** - Independent Director<BR>2. **Chiragkumar Rameshbhai Parmar** - Managing Director & CFO<BR>3. **Shvetalben S. Dataniya** - Chairman & Independent Director<BR>4. **Viren Rajeshkumar Makwana** - Additional Director<BR>5. **Jayesh L Bhavsar** - Company Secretary & Compliance Officer<BR><BR>If you need more details about any specific member or their roles, feel free to ask!

What does Padmanabh Inds. do?

Padmanabh Industries Ltd trades in agricultural goods and commodity materials, operating in the micro-cap segment of the commodity chemicals industry. The company reported net sales of 1 Cr and a net profit of 0 Cr for June 2026, with a market cap of INR 5 Cr.

Overview:<BR>Padmanabh Industries Ltd is engaged in the trading of agriculture goods and commodity & agri materials, operating within the micro-cap segment of the commodity chemicals industry.<BR><BR>History:<BR>The company was incorporated as Nilchem Industries Limited on October 24, 1994, and changed its name to Padmanabh Industries Limited on December 24, 2014. The latest quarterly results reported net sales and net profit for June 2026.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 1 Cr (Quarterly Results - Jun 2026) <BR>Most recent Net Profit: 0 Cr (Quarterly Results - Jun 2026) <BR>Market-cap value: INR 5 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 11.00 <BR>Industry P/E: 21 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 1.08 <BR>Return on Equity: 44.00% <BR>Price-to-Book: 5.16 <BR><BR>Contact Details:<BR>Address: 401 Abhishree Avenue, Nehru Nagar Circle Ambawadi Ahmedabad Gujarat : 380015 <BR>Tel: 91-79-26400200 <BR>Email: nilchem.industries@gmail.com <BR>Website: http://www.padmanabhindustries.com

Who are the peers of the Padmanabh Inds.?

Peers of Padmanabh Inds. include Emmessar Biotech, Kobo Biotech, Link Pharma Chem, Omkar Pharmachem, Sreechem Resins, Bhagawati Oxygen, Lime Chemicals, and Kuwer Industries. Padmanabh Inds. has average management risk and growth, with a 1-year return of 12.45%.

Peers: The peers of Padmanabh Inds. are Emmessar Biotech, Kobo Biotech, Link Pharma Chem, Omkar Pharmachem, Sreechem Resins, Bhagawati Oxygen, Lime Chemicals, Kuwer Industries.<BR><BR>Quality Snapshot: Good management risk is observed at Sreechem Resins, while Average management risk is found at Padmanabh Inds., Emmessar Biotech, Link Pharma Chem, Lime Chemicals, and Kuwer Industries. Below Average management risk is noted at Omkar Pharmachem. Growth is Average at Padmanabh Inds., while Below Average growth is seen at Emmessar Biotech, Link Pharma Chem, Sreechem Resins, Lime Chemicals, and Kuwer Industries, and the rest do not qualify. Capital Structure ratings show Below Average at Padmanabh Inds., Emmessar Biotech, Link Pharma Chem, Lime Chemicals, and Kuwer Industries, while the rest do not qualify.<BR><BR>Return Snapshot: Kobo Biotech has the highest 1-year return at 134.04%, while Omkar Pharmachem has the lowest with N/A, and Padmanabh Inds. has a 1-year return of 12.45%. Additionally, Sreechem Resins, Omkar Pharmachem, and Lime Chemicals have negative six-month returns.

How big is Padmanabh Inds.?

As of 31st August, Padmanabh Industries Ltd has a market capitalization of 5.00 Cr, with net sales of 0.13 Cr and a net loss of 1.64 Cr over the latest four quarters. Shareholder's funds are valued at 0.54 Cr, and total assets amount to 3.05 Cr as of March 2022.

As of 31st August, Padmanabh Industries Ltd has a market capitalization of 5.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 0.13 Cr. However, it experienced a loss of 1.64 Cr in Net Profit during the same period.<BR><BR>The latest annual period for the balance sheet is March 2022. Shareholder's Funds are valued at 0.54 Cr, while Total Assets amount to 3.05 Cr.

Which are the latest news on Padmanabh Inds.?

Should I buy, sell or hold Padmanabh Industries Ltd?

When is the next results date for Padmanabh Industries Ltd?

The next results date for Padmanabh Industries Ltd is 22 July 2026.

The next results date for Padmanabh Industries Ltd is scheduled for 22 July 2026.

Are Padmanabh Industries Ltd latest results good or bad?

Padmanabh Industries Ltd's latest results show impressive year-on-year growth in net sales and profit, with increases of 2,471.43% and 2,100.00%, respectively. However, these gains come after a history of operational challenges and losses, so caution is advised when interpreting the results.

The latest results for Padmanabh Industries Ltd indicate a mixed picture. On one hand, there has been a significant year-on-year growth in net sales, with a remarkable increase of 2,471.43% in the quarter ended December 2025 compared to the same quarter in the previous year. Additionally, the standalone net profit also saw a substantial growth of 2,100.00% during the same period.<BR><BR>However, despite these impressive percentage increases, it's essential to consider the context. The company has faced severe operational challenges in recent years, with a history of revenue collapse and persistent losses. Prior to this recent quarter, the company reported virtually no revenue, and its financial health has been characterized by negative metrics, including a negative return on capital employed and minimal promoter holding.<BR><BR>While the latest results show positive growth, they come after a long period of distress, and the company still faces significant risks, including governance concerns and a lack of institutional investor confidence. Therefore, while the latest figures may seem good in isolation, they should be viewed cautiously in light of the company's overall financial history and current operational challenges.

How has been the historical performance of Padmanabh Inds.?

Padmanabh Inds. has experienced significant financial decline, with net sales dropping from 6.29 Cr in Mar'18 to 0.14 Cr in Mar'22, and increasing losses reflected in negative operating profit and net profit after tax. Total assets also decreased from 10.36 Cr in Mar'19 to 3.05 Cr in Mar'22, indicating overall deteriorating performance.

Answer:<BR>The historical performance of Padmanabh Inds. shows significant fluctuations in its financial metrics over the years.<BR><BR>Breakdown:<BR>Padmanabh Inds. experienced a notable decline in net sales, dropping from 6.29 Cr in Mar'18 to just 0.14 Cr in Mar'22, with a peak of 1.61 Cr in Mar'20. The total operating income followed a similar trend, peaking at 6.29 Cr in Mar'18 and falling to 0.14 Cr in Mar'22. The company faced increasing total expenditure, which reached 0.90 Cr in Mar'22, up from 0.32 Cr in Mar'21. Operating profit (PBDIT) was negative in Mar'22 at -0.69 Cr, a decline from -0.22 Cr in Mar'21, and the profit before tax also worsened to -1.56 Cr in Mar'22 from -0.25 Cr in Mar'21. The net profit after tax reflected a similar downward trend, with losses increasing from -0.25 Cr in Mar'21 to -1.56 Cr in Mar'22. The company's total assets decreased from 10.36 Cr in Mar'19 to 3.05 Cr in Mar'22, while total liabilities also fell from 10.36 Cr in Mar'19 to 3.05 Cr in Mar'22. Cash flow from operating activities remained negative at -1.00 Cr in Mar'22, consistent with the previous year. Overall, Padmanabh Inds. has shown a deteriorating financial performance over the years, marked by declining sales, increasing losses, and reduced asset values.

Who are the top shareholders of the Padmanabh Inds.?

The top shareholders of Padmanabh Industries include promoter Jigisha Bhavinbhai Shah with 0.82% and public shareholder Ashish Mahendra Shah with 9.79%. Individual investors hold a significant 84.03% of the shares, with no institutional holdings reported.

The top shareholders of Padmanabh Industries include Jigisha Bhavinbhai Shah, who is the promoter with the highest holding at 0.82%. The highest public shareholder is Ashish Mahendra Shah, holding 9.79%. Additionally, individual investors collectively hold a significant portion of the company, accounting for 84.03% of the shares. There are no institutional holdings from mutual funds or foreign institutional investors.

Is Padmanabh Inds. overvalued or undervalued?

As of April 25, 2023, Padmanabh Industries is considered risky but undervalued, with a PE ratio of 5.59, significantly lower than peers like MMTC and Elitecon International, suggesting potential growth despite recent underperformance compared to the Sensex.

As of 25 April 2023, the valuation grade for Padmanabh Industries has moved from does not qualify to risky. The company is currently considered undervalued. Key ratios include a PE ratio of 5.59, an EV to EBIT of 6.15, and a PEG ratio of 0.05, indicating potential for growth despite the risks involved.<BR><BR>In comparison with peers, Padmanabh Industries' PE ratio is significantly lower than that of MMTC, which stands at 119.39, and Elitecon International, which is at 131.08. This suggests that Padmanabh may be undervalued relative to its peers in the commodity chemicals industry. Additionally, while the company's recent stock performance has lagged behind the Sensex in the year-to-date period, it has outperformed the index over the past year, reinforcing the notion of potential upside if market conditions improve.

What is the technical trend for Padmanabh Inds.?

As of May 20, 2025, Padmanabh Inds. has a bullish technical trend supported by positive MACD and KST indicators, though the RSI shows no signal and Dow Theory indicates a mildly bullish trend on the weekly chart.

As of 20 May 2025, the technical trend for Padmanabh Inds. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are both bullish, supporting the positive trend. Daily moving averages also indicate a bullish stance. The KST is bullish on both weekly and monthly time frames, reinforcing the overall bullish sentiment. However, the RSI shows no signal on both weekly and monthly charts, and the Bollinger Bands are mildly bullish. Dow Theory indicates a mildly bullish trend on the weekly chart but shows no trend on the monthly chart. Overall, the current technical stance is bullish with moderate strength.

Has Padmanabh Inds. declared dividend?

No Dividend History Available